| Cancers, Vol. 13, Pages 1088: Mid-Term Audit of a National Peritoneal Surface Malignancy Program Implementation in a Low Middle Income Country: The Moroccan Experience | Cancers | 38 days | save |  |  |  |  |
| Cancers, Vol. 13, Pages 1087: Cellular and Molecular Mechanisms Underlying Glioblastoma and Zebrafish Models for the Discovery of New Treatments | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1086: Role of Tumor-Associated Macrophages in Sarcomas | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1085: Small Non-Coding-RNA in Gynecological Malignancies | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1084: Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1083: Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1082: Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain Radiotherapy | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1081: The Burden of Post-Translational Modification (PTM)—Disrupting Mutations in the Tumor Matrisome | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1079: EphB6 Regulates TFEB-Lysosomal Pathway and Survival of Disseminated Indolent Breast Cancer Cells | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1075: Histopathological and Immune Prognostic Factors in Colo-Rectal Liver Metastases | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1080: Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1078: Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1077: Adrenocortical Carcinoma | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1076: Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1074: Pathologic Response Rates after Neoadjuvant Therapy for Sarcoma: A Single Institution Study | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1073: Glioma biopsies Classification Using Raman Spectroscopy and Machine Learning Models on Fresh Tissue Samples | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1072: The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1071: Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1069: Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1070: Time to Pregnancy, Obstetrical and Neonatal Outcomes after Breast Cancer: A Study from the Maternity Network for Young Breast Cancer Patients | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1068: VATS Pleurectomy Decortication Is a Reasonable Alternative for Higher Risk Patients in the Management of Malignant Pleural Mesothelioma: An Analysis of Short-Term Outcomes | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1067: Dive into Single, Seek out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1065: Perspective of Immune Checkpoint Inhibitors in Thymic Carcinoma | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1066: Long-Term Incidence of Advanced Colorectal Neoplasia in Patients with Serrated Polyposis Syndrome: Experience in a Single Academic Centre | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1063: Advanced Imaging Techniques for Radiotherapy Planning of Gliomas | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1064: THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1061: Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1062: Plasma Proteins and Cancer | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1060: A Phase I Dose Escalation Study of Oxaliplatin, Cisplatin and Doxorubicin Applied as PIPAC in Patients with Peritoneal Carcinomatosis | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1059: Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1058: The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1057: Clinical Benefits of Conversion Surgery for Unresectable Pancreatic Ductal Adenocarcinoma: A Single-Institution, Retrospective Analysis | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1056: Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1050: CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1049: Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1055: Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1054: CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6 | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1053: Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1052: Drug-Related Pneumonitis in Cancer Treatment during the COVID-19 Era | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1051: In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1047: HER2-/HER3-Targeting Antibody—Drug Conjugates for Treating Lung and Colorectal Cancers Resistant to EGFR Inhibitors | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1048: Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1046: Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1044: Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1045: The Role of Network Science in Glioblastoma | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1043: Reduced USP22 Expression Impairs Mitotic Removal of H2B Monoubiquitination, Alters Chromatin Compaction and Induces Chromosome Instability That May Promote Oncogenesis | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1042: The Antitumor Effects of Plasma-Activated Saline on Muscle-Invasive Bladder Cancer Cells In Vitro and In Vivo Demonstrate Its Feasibility as a Potential Therapeutic Approach | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1040: Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1041: Insulin-Like Growth Factor Binding Protein-3 Exerts Its Anti-Metastatic Effect in Aerodigestive Tract Cancers by Disrupting the Protein Stability of Vimentin | Cancers | 38 days | save | | | | |
| Cancers, Vol. 13, Pages 1039: Autophagy and Extracellular Vesicles in Colorectal Cancer: Interactions and Common Actors? | Cancers | 38 days | save | | | | |
| | 
report | next » |
| |
